Lack of androgenicity and estrogenicity of the three monomers used in Eastman's Tritan™ copolyesters

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 2196-2205

  Osimitz, Thomas G ^a   Eldridge, Melanie L ^b   Sloter, Eddie ^c   Welsh, William ^d   Ai, Ni ^d   Sayler, Gary S ^b,e   Menn, FuMin ^b   Toole, Colleen ^f  

^a Science Strategies LLC   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c WIL RESEARCH LABORATORIES   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e The Joint Institute for Biological Sciences   (United States)

^f CeeTox Inc   (United States)

Author keywords

1,4 Cyclohexanedimethanol; 2,2,4,4 Tetramethyl 1,3 cyclobutanediol; Androgenicity; Di methylterephthalate; Estrogenicity; Monomer

Indexed keywords

1,4 CYCLOHEXANEDIMETHANOL; 2,24,4 TETRAMETHYL 1,3 CYCLOBUTANEDIOL; ANDROGEN RECEPTOR; COPOLYMER; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MONOMER; OLIGOMER; PLASTIC; POLYESTER; TEREPHTHALIC ACID; TEREPHTHALIC ACID DIMETHYL ESTER; UNCLASSIFIED DRUG;

ANDROGENIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; ESTROGENICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; RECEPTOR BINDING; REPRODUCTIVE TOXICITY;

AMIDES; ANDROGENS; ANIMALS; BODY WEIGHT; CELL LINE; CYCLOHEXANES; CYCLOPROPANES; ESTROGENS; FEMALE; GENITALIA; HUMANS; MALE; MODELS, MOLECULAR; NEURAL NETWORKS (COMPUTER); ORGAN SIZE; PHTHALIC ACIDS; PLASTICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SACCHAROMYCES CEREVISIAE; SUPPORT VECTOR MACHINES; TRANSCRIPTIONAL ACTIVATION;

MAMMALIA;

EID: 84860340285     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.02.010     Document Type: Article

References (33)

1. Ball G.L., McLellan C.J., Bhat V.S. Toxicological review and oral risk assessment of terephthalic acid (TPA) and its esters: a category approach. Critical Reviews in Toxicology 2012, 42(1):28-67.
2. Casals-Casas C., Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annual Review of Physiology 2011, 73:135-162.
3. Ciocca D.R., Roig L.M. Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocrine Reviews 1995, 16(1):35-62.
4. DeLisle R.K., Yu S.J., Nair A.C., Welsh W.J. Homology modeling of the estrogen receptor subtype beta (ER-beta) and calculation of ligand binding affinities. Journal of Molecular Graphics and Modelling 2001, 20(2):155-167.
5. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an Endocrine society scientific statement. Endocrine Reviews 2009, 30(4):293-342.
6. EDSTAC, 1998. EDSTAC Final Report Chapter Three: Conceptual Framework and Principles. Available at URL: (accessed 10.07.11). http://www.epa.gov/endo/pubs/edstac/chap3v14.pdf.
7. Eldridge J.C., Stevens J.T.E. Endocrine Toxicology 2010, NY, Informa Healthcare, New York. 3rd ed.
8. Eldridge M.L., Sanseverino J., Layton A.C., Easter J.P., Schultz T.W., Sayler G.S. Saccharomyces cerevisiae BLYAS, a new bioluminescent bioreporter for detection of androgenic compounds. Applied and Environment Microbiology 2007, 73(19):6012-6018.
9. European Commission, 2011. Commission Regulation (EU) No. 10/2011 of 14 January 2011 on Plastic Materials and Articles Intended to Come into Contact with Food Text with EEA Relevance. Available at URL: (accessed 10.07.11). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:012:0001:01:EN:HTML.
10. Halden R.U. Plastics and health risks. Annual Review of Public Health 2010, 31:179-194.
11. Hong H., Fang H., Xie Q., Perkins R., Sheehan D.M., Tong W. Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor. SAR and QSAR in Environmental Research 2003, 14(5-6):373-388.
12. Jones P.A., Baker V.A., Irwin A.J., Earl L.K. Interpretation of the in vitro proliferation response of mcf-7 cells to potential oestrogens and non-oestrogenic substances. Toxicology In Vitro 1998, 12(4):373-382.
13. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Molecular Endocrinology 2005, 19(8):1951-1959.
14. Meek P.J., Liu Z., Tian L., Wang C.Y., Welsh W.J., Zauhar R.J. Shape Signatures: speeding up computer aided drug discovery. Drug Discovery Today 2006, 11(19-20):895-904.
15. Muncke J. Endocrine disrupting chemicals and other substances of concern in food contact materials: an updated review of exposure, effect and risk assessment 2010, The Journal of Steroid Biochemistry and Molecular Biology.
16. Ohashi A., Kotera H., Hori H., Hibiya M., Watanabe K., Murakami K., Hasegawa M., Tomita M., Hiki Y., Sugiyama S. Evaluation of endocrine disrupting activity of plasticizers in polyvinyl chloride tubes by estrogen receptor alpha binding assay. Journal of Artificial Organs 2005, 8(4):252-256.
17. Ohno K., Azuma Y., Date K., Nakano S., Kobayashi T., Nagao Y., Yamada T. Evaluation of styrene oligomers eluted from polystyrene for estrogenicity in estrogen receptor binding assay, reporter gene assay, and uterotrophic assay. Food and Chemical Toxicology 2003, 41(1):131-141.
18. Ohno K., Azuma Y., Nakano S., Kobayashi T., Hirano S., Nobuhara Y., Yamada T. Assessment of styrene oligomers eluted from polystyrene-made food containers for estrogenic effects in in vitro assays. Food and Chemical Toxicology 2001, 39(12):1233-1241.
19. Sanseverino J., Eldridge M.L., Layton A.C., Easter J.P., Yarbrough J., Schultz T.W., Sayler G.S. Screening of potentially hormonally active chemicals using bioluminescent yeast bioreporters. Toxicological Sciences 2009, 107(1):122-134.
20. Sanseverino J., Gupta R.K., Layton A.C., Patterson S.S., Ripp S.A., Saidak L., Simpson M.L., Schultz T.W., Sayler G.S. Use of Saccharomyces cerevisiae BLYES expressing bacterial bioluminescence for rapid, sensitive detection of estrogenic compounds. Applied and Environment Microbiology 2005, 71(8):4455-4460.
21. Shi L.M., Fang H., Tong W., Wu J., Perkins R., Blair R.M., Branham W.S., Dial S.L., Moland C.L., Sheehan D.M. QSAR models using a large diverse set of estrogens. Journal of Chemical Information and Computer Sciences 2001, 41(1):186-195.
22. Talsness C.E., Andrade A.J., Kuriyama S.N., Taylor J.A., vom Saal F.S. Components of plastic: experimental studies in animals and relevance for human health. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2009, 364(1526):2079-2096.
23. USEPA Screening Level Hazard Characterization for CHDM 2007, U.S. Environmental Protection Agency, Office of Pollution Prevention and Toxics, Washington, DC, 20460.
24. USEPA, 2008. Technical Review Document for the Endocrine Disruptor Screening Program (EDSP), Proposed Tier 1 Screening Battery. U.S. Environmental Protection Agency, Office of Prevention, Pesticides, and Toxic Substances, Office of Science Coordination and Policy, Washington, DC 20460. Available at URL: (accessed 10.11.11). http://www.epa.gov/scipoly/sap/meetings/2008/march/technical_review.pdf.
25. USFDA, 2011. Inventory of Effective Food Contact Substance (FCS) Notifications: FCN No. 1041. Available at URL: (accessed 10.07.11). http://www.accessdata.fda.gov/scripts/fcn/fcnDetailNavigation.cfm?rpt=fcsListing&id=1041.
26. Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W., Taylor R.D. Improved protein-ligand docking using GOLD. Proteins 2003, 52(4):609-623.
27. Vinggaard A.M., Niemela J., Wedebye E.B., Jensen G.E. Screening of 397 chemicals and development of a quantitative structure-activity relationship model for androgen receptor antagonism. Chemical Research in Toxicology 2008, 21(4):813-823.
28. Wagner M., Oehlmann J. Endocrine disruptors in bottled mineral water: total estrogenic burden and migration from plastic bottles. Environmental Science and Pollution Research International 2009, 16(3):278-286.
29. Wilson V.S., Bobseine K., Gray L.E. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicological Sciences: An Official Journal of the Society of Toxicology 2004, 81(1):69-77.
30. Wilson V.S., Bobseine K., Lambright C.R., Gray L.E. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicological Sciences: An Official Journal of the Society of Toxicology 2002, 66(1):69-81.
31. World Health Organization (WHO), 2002. Global Assessment of the State-of-the-Science of Endocrine Disruptors. International Programme on Chemical Safety. Available at URL: (accessed 22.11.11). http://www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/.
32. Yang C.Z., Yaniger S.I., Jordan V.C., Klein D.J., Bittner G.D. Most plastic products release estrogenic chemicals: a potential health problem that can be solved. Environmental Health Perspectives 2011, 119(7):989-996.
33. Zauhar R.J., Moyna G., Tian L., Li Z., Welsh W.J. Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design. Journal of Medicinal Chemistry 2003, 46(26):5674-5690.